| Standard Report | Premium Report | |
|---|---|---|
| Current State of the Industry |  |
|
| Market Size (industry trends) | |
|
| Market Forecast (5-year projection) | |
|
| Products/Services Breakdown | |
|
| Revenue per State | |
|
| Financial Metrics | |
|
| Salary & Compensation Statistics | |
|
| Public Company Information | |
|
| Key Private Companies | |
|
| Government Vendors | |
|
| Instant Download - Available immediately upon purchase | |
|
Download both PDF and Excel
|
|
|
| Download now: |
2024 U.S. Industry Statistics & Market Forecast - Medical and Diagnostic Laboratories
Market Size & Industry Statistics
The total U.S. industry market size for Medical and Diagnostic Laboratories:
Industry statistics cover all companies in the United States, both public and private, ranging in size from small businesses to market leaders.
In addition to revenue, the industry market analysis shows information on employees, companies, and average firm size.
Investors, banks, and business executives use growth rates and industry trends to understand the market outlook and opportunity.
| Statistics | 2019 2020 2021 2022 2023 | |
|---|---|---|
| Market Size (Total Sales/Revenue) |
Order at top of page | |
| Total Firms | ||
| Total Employees | ||
| Average Revenue Per Firm | ||
| Average Employees Per Firm | ||
| Average Revenue Per Employee | ||
Market Forecast
Market forecasts show the long term industry outlook and future growth trends. The following extended five-year forecast projects both short-term and long-term trends.
| Forecast / Industry Outlook | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| Market Forecast ($ millions) | |||||
| Projected Industry Growth Rate (%) | |||||
Industry Insights
Major trends affect the Medical and Diagnostic Laboratories industry include:- Increased demand for personalized medicine and genetic testing
- Expansion of telemedicine and remote diagnostics
- Growing use of big data and artificial intelligence for diagnostic accuracy
- Heightened regulatory scrutiny and compliance requirements
- Rising healthcare costs influencing laboratory service pricing
- Integration of advanced technologies like CRISPR and next-gen sequencing
- Increasing importance of cybersecurity measures in protecting patient data
- Greater focus on preventive care and wellness testing
- Expansion into global markets, especially in developing regions
- Shift towards multiplex testing to reduce costs and time
Product & Services Breakdown
Research products and services in the Medical and Diagnostic Laboratories industry generating sales. Note that products are broken into categories with different levels of classification.| Product Description | Number of Companies | Sales ($ millions) | Percent of Total Sales |
|---|---|---|---|
Industry Total |
|||
Laboratory Services |
|||
Anatomic Pathology |
|||
Clinical Pathology Services |
|||
General Pathology Services |
|||
Diagnostic Imaging Services |
|||
X-Ray/Radiography Imaging, Including Fluoroscopy And Mammography |
|||
Magnetic Resonance Imaging (Mri) |
|||
Computed Tomography (Ct) Scanning |
|||
Nuclear Medicine Scanning, Including Pet/Ct |
|||
Ultrasound Imaging |
|||
Electroencephalography (Eeg), Magnetoencephalography (Meg), Electrocardiography (Ekg) |
|||
Other Diagnostic Imaging Services |
|||
Rental Or Lease Of Goods And/Or Equipment |
|||
Rental Or Lease Of - All Other Goods And/Or Equipment |
|||
All Other Receipts |
|||
All Other Operating Receipts |
|||
U.S. Geographic Distribution: Revenue Statistics by State
Market Size by State ($ millions) indicates how the industry's competition is distributed throughout the country. State-level information can identify areas with higher and lower industry market share than average.
Income Statement (Average Financial Metrics)
Financial metrics provide a snapshot view of a benchmark "average" company. Key business metrics show revenue and operating costs. The data collected covers both public and private companies.| Industry Average | Percent of Sales (Industry Benchmark) |
|
|---|---|---|
| Total Revenue | Order at top of page |
|
| Operating Revenue | ||
| Cost of Goods Sold | ||
| Gross Profit | ||
Operating Expenses | ||
| Pension, profit sharing plans, stock, annuity | ||
| Repairs | ||
| Rent paid on business property | ||
| Charitable Contributions | ||
| Depletion | ||
| Domestic production activities deduction | ||
| Advertising | ||
| Compensation of officers | ||
| Salaries and wages | ||
| Employee benefit programs | ||
| Taxes and Licenses | ||
| Bad Debts | ||
| Depreciation | ||
| Amortization | ||
| Other Operating Expenses | ||
| Total Operating Expenses | ||
| Operating Income | ||
| Non-Operating Income | ||
| EBIT (Earnings Before Interest and Taxes) | ||
| Interest Expense | ||
| Earnings Before Taxes | ||
| Income Tax | ||
| Net Profit Net Income | ||
Financial Ratio Analysis
Financial ratio information can be used to benchmark how a Medical and Diagnostic Laboratories company compares to its peers. Accounting statistics are calculated from the industry-average for income statements and balance sheets.| Profitability & Valuation Ratios | Industry Average |
|---|---|
| Company valuation can be measured based on the firm's own performance, as well as in comparison against its industry competitors. These metrics show how the average company in the Medical and Diagnostic Laboratories industry is performing. | |
| Profit Margin Gross Profit Margin, Operating Profit Margin, and Net Profit Margin. Show company earnings relative to revenues. |
|
| Return on Equity (ROE) Return on Equity (ROE) is net income as a percentage of shareholders' equity. Shareholders' Equity is defined as the company's total assets minus total liabilities. ROE shows how much profits a company generates with the money shareholders invested (or with retained earnings). |
|
| Return on Assets (ROA) Return on Assets (ROA) is net income relative to total assets. The market research on Medical and Diagnostic Laboratories measures how efficiently the company leverages its assets to generate profit. ROA is calculated as Net Income divided by Total Assets. |
|
| Liquidity Ratios | Industry Average |
|---|---|
| Bankers and suppliers use liquidity to determine creditworthiness and identify potential threats to a company's financial viability. | |
| Current Ratio Measures a firm's ability to pay its debts over the next 12 months. |
|
| Quick Ratio (Acid Test) Calculates liquid assets relative to liabilities, excluding inventories. |
|
| Efficiency Ratios - Key Performance Indicators | Industry Average |
|---|---|
| Measure how quickly products and services sell, and effectively collections policies are implemented. | |
| Receivables Turnover Ratio If this number is low in your business when compared to the industry average in the research report, it may mean your payment terms are too lenient or that you are not doing a good enough job on collections. |
|
| Average Collection Period Based on the Receivables Turnover, this estimates the collection period in days. Calculated as 365 divided by the Receivables Turnover |
|
| Inventory Turnover A low turnover rate may point to overstocking, obsolescence, or deficiencies in the product line or marketing effort. |
|
| Fixed-Asset Turnover Generally, higher is better, since it indicates the business has less money tied up in fixed assets for each dollar of sales revenue. |
|
Compensation & Salary Surveys for Employees
Compensation statistics provides an accurate assessment of industry-specific jobs and national salary averages. This information can be used to identify which positions are most common, and high, low, and average annual wages.| Title | Percent of Workforce | Bottom Quartile | Average (Median) Salary | Upper Quartile |
|---|---|---|---|---|
| Management Occupations | 6% | Order at top of page |
||
| Chief Executives | 0% | |||
| General and Operations Managers | 1% | |||
| Healthcare Practitioners and Technical Occupations | 40% | |||
| Health Technologists and Technicians | 35% | |||
| Clinical Laboratory Technologists and Technicians | 22% | |||
| Diagnostic Related Technologists and Technicians | 11% | |||
| Radiologic Technologists and Technicians | 5% | |||
| Healthcare Support Occupations | 18% | |||
| Other Healthcare Support Occupations | 18% | |||
| Miscellaneous Healthcare Support Occupations | 18% | |||
| Phlebotomists | 15% | |||
| Office and Administrative Support Occupations | 22% | |||
| Information and Record Clerks | 7% | |||
| Material Recording, Scheduling, Dispatching, and Distributing Workers | 5% | |||
Medical and Diagnostic Laboratories Competitor Landscape & Key Companies [PREMIUM]
The most influential companies in the Medical and Diagnostic Laboratories industry and adjacent industries either have large market share or are developing new business models and methods that could disrupt the status quo. We look at leading and emerging companies in the Medical and Diagnostic Laboratories industry and adjacent sectors:| Market Leaders: Direct Competitors Companies with the largest market share, focused in this industry |
Market leaders: Diversified Competitors Largest companies that have diversified operations in this and other industries |
| Innovators: Direct Competitors Innovative, Emerging, and Disruptive Companies that may influence the future direction of the industry. |
Innovators: Diversified Competitors Innovators and Disruptors in adjacent industries that may also affect the Medical and Diagnostic Laboratories industry. |
Source:
Innovation News
- Jun 13, 2024: Exact Sciences Thrive patents Detecting Gastric Neoplasm
- Jun 13, 2024: Exact Sciences Thrive patents Mutation Detection Assay
- Jun 13, 2024: Modernatx patents Lipid Nanoparticles And Polynucleotides Encoding Ornithine Transcarbamylase For The Treatment Of Ornithine Transcarbamylase Deficiency
- May 24, 2024: IVIEW Therapeutics raises $15 million in funding.
- May 23, 2024: Gemini Bioproducts raises $5 million in funding.
- May 01, 2024: Abacus Insights raises $41 million in funding.
- Jan 24, 2024: Azurity Pharmaceuticals trademarks "RINHIBLY" - pharmaceutical preparations for use in oncology
- Jan 22, 2024: Verinomics trademarks "VERINOMICS" - Genomic testing for scientific research and commercial purposes
- Jan 12, 2024: Azurity Pharmaceuticals trademarks "DANZITEN" - pharmaceutical preparations for use in oncology
Recent Federal Contracts for Medical and Diagnostic Laboratories
- Apr 02, 2024: QUEST DIAGNOSTICS INCORPORATED (Secaucus, NJ) awarded $55,000
- Apr 02, 2024: LABORATORY CORPORATION OF AMERICA (Burlington, NC) awarded $4,262
- Apr 02, 2024: D & D LABORATORY, LLC (Greenwood, SC) awarded $14,605
- Apr 02, 2024: CDL NUCLEAR TECHNOLOGIES, LLC (Wexford, PA) awarded $2,300
- Apr 02, 2024: NORTHLAND HEALTHCARE ALLIANCE (Bismarck, ND) awarded $479,700
- Apr 02, 2024: AGILENT TECHNOLOGIES INC (Wilmington, DE) awarded $376,337
Related Reports
Can't find what you're looking for? We have over a thousand
market research reports.
Ask us and an analyst will help you find what you need.